1.
Perreault L, Skyler JS, Rosenstock J. Novel therapies with precisionmechanisms for type 2 diabetes mellitus. Nat Rev Endocrinol 2021;17: 364-77.
2.
Unwin, N, Whiting, D, Guariguata, L. Diabetes Atlas. 5th ed.Brussels: International Diabetes Federation; 2012.
3.
Gutierrez R, Simon SA. Chemosensory processing in the taste-reward pathway. Flavour Fragr J 2011; 26: 231-8.
4.
Kitamura A, Torii K, Uneyama H, Niijima A. Role played by afferentsignals from olfactory, gustatory and gastrointestinal sensors inregulation of autonomic nerve activity. Biol Pharm Bull 2010; 33:1778-82.
5.
Rolls ET. Smell, taste, texture, and temperature multimodalrepresentations in the brain, and their relevance to the control ofappetite. Nutr Rev 2004; 62: 193-204.
6.
Bloomfeld RS, Graham BG, Schiffman SS, Killenberg PG.Alterations of chemosensory function in end-stage liver disease.Physiol Behav 1999; 66: 203-7.
7.
Barragán R, Coltell O, Portolés O, et al. Bitter, sweet, salty, sour andumami taste perception decreases with age: Sex-specific analysis,modulation by genetic variants and taste-preference associations in18 to 80 year-old subjects. Nutrients 2018; 10: 1539.
8.
Imoscopi A, Inelmen EM, Sergi G, Miotto F, Manzato E. Taste lossin the elderly: epidemiology, causes and consequences. Aging ClinExp Res 2012; 24: 570-9.
9.
Lohman TG, Roche AF, Martorell R. Anthropometricstandardization reference manual. 1st ed. Champaign - IL: HumanKinetics Books; 1988. Anthoropometric Standardization ReferenceManual. Human Kinetics Books; 1998
10.
Mueller C, Kallert S, Renner B, et al. Quantitative assessment ofgustatory function in a clinical context using impregnated" tastestrips". Rhinology 2003; 41: 2-6.
11.
Mojet J, Christ-Hazelhof E, Heidema J. Taste perception with age:generic or specific losses in threshold sensitivity to the five basictastes? Chem Senses 2001; 26: 845-60.
12.
Pugnaloni S, Alia S, Mancini M, et al. A study on the relationshipbetween type 2 diabetes and taste function in patients with goodglycemic control. Nutrients 2020; 12: 1112.
13.
Landis BN, Welge-Luessen A, Brämerson A, et al. “Taste Strips”-arapid, lateralized, gustatory bedside identification test based onimpregnated filter papers. J Neurol 2009; 256: 242-8.
14.
Welge-Lüssen A, Dörig P, Wolfensberger M, Krone F, Hummel T.A study about the frequency of taste disorders. J Neurol 2011; 258:386-92.
15.
Vignini A, Borroni F, Sabbatinelli J, et al. General decrease oftaste sensitivity is related to increase of BMI: A simple method tomonitor eating behavior. Dis Markers 2019; 2019: 1-8.
16.
Yu JH, Shin MS, Lee JR, et al. Decreased sucrose preference inpatients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2014;104: 214-9.
17.
Gondivkar SM, Indurkar A, Degwekar S, Bhowate R. Evaluation ofgustatory function in patients with diabetes mellitus type 2. OralSurg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 876-80.
18.
Vidanage D, Prathapan S, Wasalathanthri S, Hettiarachchi P.Factors associated with sweet taste sensitivity in patients with type2 diabetes mellitus (T2DM). J Ruhunu Clin Soc 2020; 25: 25-9.
19.
Drewnowski A, Henderson SA, Cockroft JE. Genetic sensitivityto 6-n-propylthiouracil has no influence on dietary patterns, bodymass indexes, or plasma lipid profiles of women. J Am Diet Assoc2007; 107: 1340-8.
20.
Salbe AD, DelParigi A, Pratley RE, Drewnowski A, Tataranni PA.Taste preferences and body weight changes in an obesity-pronepopulation. Am J Clin Nutr 2004; 79: 372-8.
21.
Tucker RM, Kaiser KA, Parman MA, George BJ, Allison DB, MattesRD. Comparisons of fatty acid taste detection thresholds in peoplewho are lean vs. overweight or obese: a systematic review and meta-analysis. PloS one 2017; 12: e0169583.
22.
Stewart JE, Feinle-Bisset C, Golding M, Delahunty C, Clifton PM,Keast RS. Oral sensitivity to fatty acids, food consumption and BMIin human subjects. Br J Nutr 2010; 104: 145-52.
23.
Proserpio C, Laureati M, Bertoli S, Battezzati A, Pagliarini E.Determinants of obesity in Italian adults: the role of taste sensitivity,food liking, and food neophobia. Chem Senses 2016; 41: 169-76.
24.
Hardikar S, Höchenberger R, Villringer A, Ohla K. Highersensitivity to sweet and salty taste in obese compared to leanindividuals. Appetite 2017; 111: 158-65.
25.
Le Floch JP, Le Lievre G, Sadoun J, Perlemuter L, Peynegre R,Hazard J. Taste impairment and related factors in type I diabetesmellitus. Diabetes care. 1989; 12: 173-8.
26.
Bustos-Saldaña R, Alfaro-Rodríguez M, de la Luz Solís-Ruiz M,Trujillo-Hernández B, Pacheco-Carrasco M, Vázquez-JiménezC. Taste sensitivity diminution in hyperglycemic type 2 diabeticspatients. Rev Med Inst Mex Seguro Soc 2009; 47: 483-8.
27.
Le Floch JP, Le Lièvre G, Labroue M, Paul M, Peynegre R,Perlemuter L. Smell dysfunction and related factors in diabeticpatients. Diabetes care 1993; 16: 934-7.
28.
Yazla S, Özmen S, Kıyıcı S, Yıldız D, Haksever M, Gencay S.Evaluation of olfaction and taste function in type 2 diabetic patientswith and without peripheral neuropathy. Observational Study2018; 34: e2973.
29.
Perros P, MacFarlane TW, Counsell C, Frier BM. Altered tastesensation in newly-diagnosed NIDDM. Diabetes care 1996; 19:768-70.
30.
Chochinov RH, Ullyot GLE, Moorhouse JA. Sensory perceptionthresholds in patients with juvenile diabetes and their closerelatives. N Engl J Med 1972; 286: 1233-7.
31.
Naka A, Riedl M, Luger A, Hummel T, Mueller CA. Clinicalsignificance of smell and taste disorders in patients with diabetesmellitus. Eur Arch Otorhinolaryngol 2010; 267: 547-50.
32.
Weinstock RS, Wright HN, Smith DU. Olfactory dysfunction indiabetes mellitus. Physiol Behav 1993; 53: 17-21.
33.
Latha G, Chandrashekar D, Puranik N. Altered taste threshold inchronic Type 2 diabetes mellitus. Natl J Physiol Pharm Pharmacol2018; 8: 569-74.
34.
Khobragade R, Wakode S, Kale A. Duration of Diabetes Mellitusand Taste Threshold. Indian J Physiol Pharmacol 2012; 56: 42-7.
35.
Epstein F, Schiffman S. Taste and smell in disease. N Engl J Med1983; 308: 1275-9.
36.
Negrato CA, Tarzia O. Buccal alterations in diabetes mellitus.Diabetol Metab Syndr 2010; 2: 1-11.
37.
Ohkoshi N, Shoji S. Reversible ageusia induced by losartan: a casereport. Eur J Neurol2002; 9: 315-21.
38.
Schlienger R, Saxer M, Haefeli W. Reversible ageusia associatedwith losartan. Lancet 1996; 347: 471-2.
39.
Lee AJ. Metformin in noninsulin-dependent diabetes mellitus.Pharmacotherapy 1996; 16: 327-51.